TMCI
Treace Medical Concepts IncHenter pris…
Værdiansættelse (TTM)
Kursudvikling
Kun 117 handelsdage i databasen. Viser al tilgængelig historik.
Data-readiness
10 års prishistorik er idealet for høj confidence.
- Prishistorik
- 0,2 år
- Pris-dage
- 58
- Årsregnskaber
- 8
- Peers
- 0/0
- Valuation
- 3/6
- Fundamentals
- 8/8
- Datovindue
- 2026-02-17 til 2026-05-08
Blokkere
- Raw confidence is below the 0.95 high-confidence guardrail.
Mangler før højere confidence
- Mangler ca. 9,8 års prishistorik før ideal/full.
- Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
- Kør compute-multiples for manglende valuation metrics.
Seneste assessment
TMCI vurderet 2026-06-10
Raw confidence is below the 0.95 high-confidence guardrail.
Stores exit-aware fields without issuing sell scores yet.
Current drawdown: Future exit logic can use drawdown from recent high.
Trend break: Future exit logic can use moving-average trend breaks.
Compares price paid with earnings, cash-generation proxies and sales.
P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.
Earnings yield: Earnings yield is the inverse P/E lens.
Checks trend, momentum and current damage from recent highs.
6M momentum: Positive medium-term momentum confirms sponsorship.
Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.
Checks whether the assessment has enough recent price, fundamental and valuation data.
Price history depth: More than one trading year gives the technical pillar enough context.
Latest price freshness: Latest live or EOD price should be recent.
Treats macro as context, not a standalone trading instruction.
VIX: Normal volatility is supportive; panic or complacency is less clean.
10Y-2Y curve: Positive yield curve lowers recession stress.
Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.
Revenue growth 3Y: Sustained top-line growth supports durable compounding.
Gross margin: High gross margin gives room for reinvestment and downturns.
Adds relative context when sector peers have comparable data.
Peer count: Peer context is only scored when comparable data exists.
P/E vs peers: P/E relative valuation needs both own multiple and peer median.
Insider activity
| Dato | Person | Rolle | Type | Antal | Værdi | Kilde |
|---|---|---|---|---|---|---|
| 24.8.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 11.000 | 47.731 USD | sec |
| 21.8.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 5.000 | 21.748 USD | sec |
| 20.8.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 39.944 | 177.176 USD | sec |
| 9.8.2026 | Elder Scot Michael | Chief Legl & Comp Off, CorpSec | · ANDET | -16.253 | — | sec |
| 9.8.2026 | Scanlan Sean F. | Chief Innovation Officer | · ANDET | -9.814 | — | sec |
| 9.8.2026 | Hair Mark | Chief Financial Officer | · ANDET | -37.102 | — | sec |
| 11.6.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 22.887 | 92.541 USD | sec |
| 10.6.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 29.430 | 118.426 USD | sec |
| 1.6.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 50.000 | 177.915 USD | sec |
| 28.5.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 61.202 | 184.824 USD | sec |
| 27.5.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 49.810 | 143.189 USD | sec |
| 26.5.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 4.508 | 12.576 USD | sec |
| 19.5.2026 | BAKEWELL JOHN K | — | · ANDET | 30.000 | — | sec |
| 19.5.2026 | Kiernan Jane E | — | · ANDET | 30.000 | — | sec |
| 19.5.2026 | Jain Deepti | — | · ANDET | 30.000 | — | sec |
| 19.5.2026 | Berry Lance A | — | · ANDET | 30.000 | — | sec |
| 19.5.2026 | HAMILTON LAWRENCE W | — | · ANDET | 30.000 | — | sec |
| 19.5.2026 | Hanna Betsy | — | · ANDET | 30.000 | — | sec |
| 14.5.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 61.750 | 161.495 USD | sec |
| 13.5.2026 | Treace John T. | Chief Executive Officer | ▲ KØB | 49.013 | 120.533 USD | sec |
Earnings
| Quarter | Date | EPS actual | EPS est | EPS surprise | Revenue surprise | |
|---|---|---|---|---|---|---|
| 2026Q1 | 30.4.2026 | -0,12 | -0,31 | +62.8% | +62.8% | Beat |
| 2025Q4 | 30.1.2026 | -0,08 | -0,14 | +44.1% | +44.1% | Beat |
| 2025Q3 | 30.10.2025 | -0,22 | -0,27 | +18.2% | +18.2% | Beat |
| 2025Q2 | 30.7.2025 | -0,26 | -0,29 | +9.8% | +9.8% | Beat |